pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Aug 4·1 min read
save

Akido expands AI-driven patient intake and diagnostic tools to 100 clinics

Aug 4, 2026·read at Endpoints ↗DealPositive

Akido, a health‑technology startup, announced it will deploy its artificial‑intelligence platform for patient intake and diagnostic assistance in 100 clinics.

The AI system captures patient information during check‑in and generates suggested diagnoses and treatment options for clinicians, aiming to streamline workflows and improve early detection.

The move follows rapid interest in AI‑driven “doctor” tools since the concept emerged about a year ago, with several startups now offering similar services.

Akido’s expansion signals growing confidence among healthcare providers in using AI to augment clinical decision‑making, though the technology remains supplemental to physician judgment.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Akido is expanding AI for patient intake and diagnoses across 100 clinics”

read at Endpoints ↗
89 words · retrieved Aug 4
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 2h agoAll 50 states sign up for most favored nation prices under Medicaid, Trump saysEndpoints
  • 3h agoFDA approves Lilly's oral SERD combo for second-line breast cancer therapyEndpoints
  • 5h agoPost-Hoc Live: The China Biotech Debate goes to WashingtonEndpoints
  • 6h agoCHMP backs Novo’s hemophilia A drug and seven other medicinesEndpoints
  • 6h agoFDA says initial rejections of new drugs have declinedEndpoints